A Pharmaceutical composition comprising 6 - 4 - (1 - Cyclohexyl - 1h-tetrazol-5-yl) butoxy - 3,4-dihydro - 2 (1H) - quinolinona (Cilostazol and aspirin in adequate quantities to obtain increased antiplatelet activity

摘要

A Pharmaceutical composition that combines pharmacologically useful quantities of 6 - [4 - (1 - Cyclohexyl - 1h-tetrazol-5-yl) butoxy] - 3,4-dihydro - 2 (1H) - quinolinona (Cilostazol) and ACETYLSALICYLIC ACID (aspirin), which is a Pharmaceutical Compound with antiplatelet activity incr Ementada and Complementary effect for the treatment of symptomatic atherosclerotic artery disease.The object of this Pharmaceutical formulation works on the Prevention of ischaemic and thrombotic vascular accidents - in the Symptomatic relief of peripheral arterial disease.